Johnson & Johnson completes $6.5B takeover of Momenta

Johnson & Johnson completes $6.5B takeover of Momenta



In autoimmune diseases, the antibodies attack or damage proteins, cells and tissues in the host's body, J&J said, adding that they can often have "devastating consequences."